Virus Filtration Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Viral Filtration Market Analysis

The Virus Filtration Market size is estimated at USD 4.87 billion in 2024, and is expected to reach USD 6.80 billion by 2029, growing at a CAGR of 6.89% during the forecast period (2024-2029).

The outbreak of COVID-19 worldwide is expected to show a positive impact on the market because sterilization is crucial for the removal of all microbes, such as bacteria, fungi, viruses, and protozoa, which may contaminate medicinal drugs, vaccines, or alternative substances, and thereby, present health hazards. In a hospital burdened with COVID-19 patients, the SARS-CoV-2 virus was successfully removed from the air using portable air filters, according to a study published in Springer Nature Limited in October 2021. The findings suggested that air filters may decrease SARS-CoV-2 infection risk among hospital patients and personnel. It can thus be concluded that the demand for virus filters increased significantly during the pandemic.

Initiatives such as investing in a new facility for biopharmaceutical drug development for COVID were key factors in market growth. Such facilities require virus filtration during drug development to maintain their sterilized condition. For instance, Clean Cells invested USD 15 million in a new manufacturing facility in Montaigu-Vendée in September 2021. The business, supported by healthcare investment fund ArchiMed, aims to play a significant part in accelerating the development and time-to-market of innovative COVID-19 medicines and vaccines by quadrupling its analysis and production capacity for biopharmaceuticals.

A few other factors that can be attributed to the growth of the virus filtration market are increasing R&D spending, increasing demand for biologics, and the adoption of single-use technologies. Increasing investment by public and private organizations for drug development is another boost for the market as such investments increase the number of clinical trials and production of drugs that require virus filtration to keep the final drug pure. According to a November 2021 update, the federal government has allocated USD 5.8 million to fund attempts to eradicate cervical cancer in Australia by 2035. By the end of 2022, a National Cervical Cancer Elimination Strategy would be developed with the assistance of the financing provided to the Australian Centre for the Prevention of Cervical Cancer (ACPCC). The government will also utilize the funds to support Compass, Australia's largest clinical study of its kind, which looks at the connections between the HPV vaccine and HPV screening.

Several market players are engaged in the implementation of strategic initiatives such as investment for innovative biologic development which require virus filtration. In February 2021, Hangzhou Sciwind Biosciences Co. Ltd (Sciwind), a clinical-stage biopharmaceutical company, received USD 37 Million Series B financing from LYFE Capital to accelerate the research and development of innovative biologics in the therapeutic area of chronic metabolic and immunological diseases. Similarly, in July 2021, AbbVie expanded its global operations in the United States for contract manufacturing (CMO) and end-to-end capability for CMO clients. However, stringent regulations on the validation of filtration products are expected to hinder the market growth.

Viral Filtration Market Trends

This section covers the major market trends shaping the Virus Filtration Market according to our research experts:

The Vaccines and Therapeutics Segment is Expected to Hold a Majority Share of the Market Over the Forecast Period

Viral Filtration Industry Segmentation

Virus filtration is an important step in the biopharmaceutical industry, as it ensures that the products are adequately purified to be fit for consumption. Virus filtration also helps to optimize process economics and prevents the loss of valuable products. The Virus Filtration Market is segmented by Products (Filtration Systems, Kits, Reagents and Consumables, and Services), Application (Biological (Vaccines and Therapeutics, Blood and Blood Products, Cellular and Gene Therapy Products, Tissue and Tissue Products, and Other Products), Medical Devices, Water Purification, and Air Purification), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.